| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/INFDIS/158.3.615 |
| P698 | PubMed publication ID | 3261763 |
| P50 | author | Roel Coutinho | Q2246926 |
| P2093 | author name string | Goudsmit J | |
| van der Noordaa J | |||
| Lange JM | |||
| de Wolf F | |||
| Schellekens PT | |||
| Houweling JT | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV/AIDS | Q12199 |
| antibody | Q79460 | ||
| P304 | page(s) | 615-622 | |
| P577 | publication date | 1988-09-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. | |
| P478 | volume | 158 |
| Q37186669 | A Novel Astrovirus-Like RNA Virus Detected in Human Stool |
| Q68090765 | Actuarial rate of clinical and biological progression in a cohort of 250 HIV-1-seropositive subjects. Laennec HIV Study Group |
| Q41952389 | Antibody recognition of amino acid divergence within an HIV-1 neutralization epitope |
| Q37176797 | Antibody response to human immunodeficiency virus type 1 protease according to risk group and disease stage |
| Q41779356 | Association of antibodies blocking HIV-1 gp 160-sCD4 attachment with virus neutralizing activity in human sera |
| Q34044972 | Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection |
| Q68325308 | Clinical signs and laboratory markers in predicting progression to AIDS in HIV–1 infected patients |
| Q45779907 | Clinical utility of an enhanced human immunodeficiency virus type 1 p24 antigen capture assay |
| Q45246332 | Cytomegalovirus and human herpesvirus 8 DNA detection in peripheral blood monocytic cells of AIDS patients: correlations with the presence of Kaposi's sarcoma and CMV disease |
| Q40541784 | DNA inoculation as a novel vaccination method against human retroviruses with rheumatic disease associations |
| Q45874694 | Delayed hypersensitivity skin tests in prognosis of human immunodeficiency virus infection |
| Q38900270 | Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay |
| Q37181428 | Detection and quantitation of human immunodeficiency virus-infected peripheral blood mononuclear cells by flow cytometry |
| Q33958026 | Detection of human immunodeficiency virus type 1 nucleocapsid protein p7 in vitro and in vivo. |
| Q34581195 | Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging |
| Q33373500 | Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study |
| Q33638209 | Evaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studies |
| Q45789467 | Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells from human immunodeficiency virus-infected individuals |
| Q33979751 | Genome-wide association scan in HIV-1-infected individuals identifying variants influencing disease course. |
| Q33932589 | HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients |
| Q68097695 | HIV1 3' ORF is open in pathological tissue and accelerates viral replication in primary lymphocytes |
| Q43450746 | Helper T-cell responses in children infected with human immunodeficiency virus type 1 |
| Q38469469 | Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour |
| Q36690417 | Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity |
| Q45853369 | Humoral immune responses to gag and env proteins from human immunodeficiency virus type 1 in hemophiliac patients |
| Q40211373 | Immune response to a major epitope of p24 during infection with human immunodeficiency virus type 1 and implications for diagnosis and prognosis |
| Q45094299 | Immune responses to fractionated cytomegalovirus (CMV) antigens after HIV infection. Loss of cellular and humoral reactivity to antigens recognized by HIV-, CMV+ individuals |
| Q67465146 | Immunodominant Epitopes of HIV-1 p17 and p24 |
| Q45872653 | Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen |
| Q83352082 | Impact of CCR5 Delta32/+ deletion on herpes zoster among HIV-1-infected homosexual men |
| Q71420861 | Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ T cells |
| Q41396869 | Increased number of single-LTR HIV-1 DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivo |
| Q35848446 | Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies |
| Q35874055 | Intrapatient sequence variation of the gag gene of human immunodeficiency virus type 1 plasma virions |
| Q43740610 | Is there an association between periodontal condition and HIV infection? |
| Q36519329 | Isolation of human immunodeficiency virus type 1 (HIV-1) RNA from feces by a simple method and difference between HIV-1 subpopulations in feces and serum |
| Q36782827 | Linear B-cell epitopes of the major core protein of human immunodeficiency virus types 1 and 2 |
| Q35826458 | Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity |
| Q45080010 | Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS. |
| Q44230412 | Low AIDS attack rate among Dutch haemophiliacs compared to homosexual men: a correlate of HIV antigenaemia frequencies |
| Q43897702 | Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men. |
| Q67889124 | Low-dose zidovudine in combination with either acyclovir or lymphoblastoid interferon-alpha in asymptomatic HIV-infected patients: a pilot study |
| Q64968778 | Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users. |
| Q68093387 | Lymphocyte ectoenzyme activity compared in healthy persons and patients seropositive to or at high risk of HIV infection |
| Q28340645 | Markers for progression to acquired immune deficiency syndrome and zidovudine treatment of asymptomatic patients |
| Q36640801 | Markers predicting progression of human immunodeficiency virus-related disease |
| Q39439722 | Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture |
| Q38332760 | Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution |
| Q39507412 | Nonradioactive techniques for measurement of in vitro T-cell proliferation: alternatives to the [(3)H]thymidine incorporation assay |
| Q24634681 | Pathogenesis of human immunodeficiency virus infection |
| Q68308654 | Periodontal disease in HIV-infected patients in relation to lymphocyte subsets and specific micro-organisms |
| Q34130886 | Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease |
| Q35171839 | Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone |
| Q37192482 | Quantitation of antibody reactivity to human immunodeficiency virus (type 1) proteins and glycoproteins on Western immunoblots by reflectance densitometry |
| Q73042211 | Quantitation of soluble E-receptor of T lymphocytes in serum from HIV-1 positive patients |
| Q40337750 | Quantitative analysis of CD4+ T cell function in the course of human immunodeficiency virus infection. Gradual decline of both naive and memory alloreactive T cells |
| Q72670771 | Recovery of antitumor CD4+ T cell responsiveness, suppressed in the tumor-bearing state, by release from tumor burden |
| Q46721319 | Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts |
| Q38206226 | Role of CD4 in normal immunity and HIV infection |
| Q36527120 | Serologic and immunologic markers in the course of HIV-1 infection |
| Q36506052 | Short-term predictions of HIV prevalence and AIDS incidence |
| Q43984746 | Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1. |
| Q36522162 | Stability of free and complexed human immunodeficiency virus type 1 antigen at 4 degrees C and at room temperature |
| Q55231913 | Suppression of anti-tumor CD4+ T cell responsiveness in the tumor-bearing state and its recovery in in vitro culture free of tumor burden. |
| Q38366893 | The immunopathogenesis of HIV infection |
| Q36445062 | The management of HIV-related illness in the emergency department |
| Q24656950 | Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies |
| Q36830775 | Use of TrpE/Gag fusion proteins to characterize immunoreactive domains on the human immunodeficiency virus type 1 core protein. |
Search more.